ArticleHeliyon2023

Dapagliflozin impedes endothelial cell senescence by activating the SIRT1 signaling pathway in type 2 diabetes.

Shi Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.